BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 27042802)

  • 1. Monte Carlo dosimetric parameter study of a new (32)P brachytherapy source.
    Wu J; Huang J; Long F; Wang C; Wu Z; Gou C
    Br J Radiol; 2016 Jun; 89(1062):20150783. PubMed ID: 27042802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dosimetric characterization of the M-15 high-dose-rate Iridium-192 brachytherapy source using the AAPM and ESTRO formalism.
    Ho Than MT; Munro Iii JJ; Medich DC
    J Appl Clin Med Phys; 2015 May; 16(3):5270. PubMed ID: 26103489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EGSnrc-based Monte Carlo dosimetry of CSA1 and CSA2 137Cs brachytherapy source models.
    Selvam TP; Sahoo S; Vishwakarma RS
    Med Phys; 2009 Sep; 36(9):3870-9. PubMed ID: 19810459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experimental and theoretical determination of dosimetric characteristics of IsoAid ADVANTAGE 125I brachytherapy source.
    Meigooni AS; Hayes JL; Zhang H; Sowards K
    Med Phys; 2002 Sep; 29(9):2152-8. PubMed ID: 12349937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dosimetric characteristics of the new RadioCoil 103Pd wire line source for use in permanent brachytherapy implants.
    Meigooni AS; Zhang H; Clark JR; Rachabatthula V; Koona RA
    Med Phys; 2004 Nov; 31(11):3095-105. PubMed ID: 15587663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monte carlo investigation of the dosimetric properties of the new 103Pd BrachySeedPd-103 Model Pd-1 source.
    Chan GH; Prestwich WV
    Med Phys; 2002 Sep; 29(9):1984-90. PubMed ID: 12349919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dosimetry characterization of 32P intravascular brachytherapy source wires using Monte Carlo codes PENELOPE and GEANT4.
    Torres J; Buades MJ; Almansa JF; Guerrero R; Lallena AM
    Med Phys; 2004 Feb; 31(2):296-304. PubMed ID: 15000615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monte Carlo dosimetric characterization of the IsoAid ADVANTAGE 103Pd brachytherapy source.
    Sowards KT
    J Appl Clin Med Phys; 2007 Mar; 8(2):18-25. PubMed ID: 17592461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monte Carlo dosimetry of a new (90)Y brachytherapy source.
    Junxiang W; Shihu Y; Jing H; Fengxiang L; Chengkai W; Zhangwen W; Qing H; Chengjun G
    J Contemp Brachytherapy; 2015 Oct; 7(5):397-406. PubMed ID: 26622247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monte Carlo calculations and experimental measurements of the TG-43U1-recommended dosimetric parameters of 125I (Model IR-Seed2) brachytherapy source.
    Sheikholeslami S; Nedaie HA; Sadeghi M; Pourbeigy H; Shahzadi S; Zehtabian M; Hasani M; Meigooni AS
    J Appl Clin Med Phys; 2016 Jul; 17(4):430-441. PubMed ID: 27455485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monte Carlo calculations and experimental measurements of dosimetric parameters of the IRA-103Pd brachytherapy source.
    Sadeghi M; Raisali G; Hosseini SH; Shavar A
    Med Phys; 2008 Apr; 35(4):1288-94. PubMed ID: 18491522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monte Carlo characterization of a new Yb-169 high dose rate source for brachytherapy application.
    Cazeca MJ; Medich DC; Munro JJ
    Med Phys; 2010 Mar; 37(3):1129-36. PubMed ID: 20384248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monte Carlo dosimetric study of best industries and Alpha Omega Ir-192 brachytherapy seeds.
    Ballester F; Granero D; PĂ©rez-Calatayud J; Casal E; Puchades V
    Med Phys; 2004 Dec; 31(12):3298-305. PubMed ID: 15651612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experimental measurements and Monte Carlo calculations of dosimetric parameters of the IRA1-103Pd brachytherapy source.
    Sadeghi M; Hosseini SH; Raisali G
    Appl Radiat Isot; 2008 Oct; 66(10):1431-7. PubMed ID: 18387806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monte Carlo calculation of dosimetry parameters for the IR08-103Pd brachytherapy source.
    Saidi P; Sadeghi M; Shirazi A; Tenreiro C
    Med Phys; 2010 Jun; 37(6):2509-15. PubMed ID: 20632562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Theoretical and experimental determination of dosimetric characteristics for ADVANTAGE Pd-103 brachytherapy source.
    Meigooni AS; Dini SA; Awan SB; Dou K; Koona RA
    Appl Radiat Isot; 2006 Aug; 64(8):881-7. PubMed ID: 16713277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monte Carlo and experimental characterization of the first AMIRS 103Pd brachytherapy source.
    Raisali G; Ghonchehnazi MG; Shokrani P; Sadeghi M
    Appl Radiat Isot; 2008 Dec; 66(12):1856-60. PubMed ID: 18657981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Monte Carlo evaluation of the dosimetric characteristics of the EchoSeed Model 6733 (125)I brachytherapy source.
    Sowards KT; Meigooni AS
    Brachytherapy; 2002; 1(4):227-32. PubMed ID: 15062171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics of miniature electronic brachytherapy x-ray sources based on TG-43U1 formalism using Monte Carlo simulation techniques.
    Safigholi H; Faghihi R; Jashni SK; Meigooni AS
    Med Phys; 2012 Apr; 39(4):1971-9. PubMed ID: 22482618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dosimetric characteristics of the Pharma Seed model BT-125-I source.
    Popescu CC; Wise J; Sowards K; Meigooni AS; Ibbott GS
    Med Phys; 2000 Sep; 27(9):2174-81. PubMed ID: 11011748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.